Monoamine Oxidase A Substrates
- Monoamine Oxidase A Substrates
- Accession Number
Drugs that are metabolized either partially or completely by Monoamine Oxidase A (MAO-A) enzyme.
Drug Drug Description Rizatriptan A triptan used to treat migraines with or without aura. Sumatriptan A serotonin receptor agonist used to treat migraines and cluster headaches. Almotriptan A 5-HT1B/1D receptor agonist used to treat migraines. Zolmitriptan A member of the triptan class of 5-HT(1B/1D/1F) receptor agonist drugs used for the acute treatment of migraine with or without aura in adults. Naratriptan A 5-HT1B/1D receptor agonist used to treat migraines. Phenylephrine An alpha-1 adrenergic agonist used in the management of hypotension, generally in the surgical setting associated with the use of anesthetics. Phenelzine A monoamine oxidase inhibitor used to treat atypical, nonendogenous, or neurotic depression. Dopamine A catecholamine neurotransmitter used to treat hemodynamic imbalances, poor perfusion of vital organs, low cardiac output, and hypotension. Eravacycline A tetracycline antibiotic used to treat complicated intra-abdominal infections. Bufotenine A hallucinogenic serotonin analog found in frog or toad skins, mushrooms, higher plants, and mammals, especially in the brains, plasma, and urine of schizophrenics. Bufotenin has been used as a... Bicifadine For the treatment of pain. Sertraline A selective serotonin reuptake inhibitor (SSRI) indicated to treat major depressive disorder, social anxiety disorder and many other psychiatric conditions. Escitalopram A selective serotonin re-uptake inhibitor used in the treatment of major depressive disorder (MDD), generalized anxiety disorder (GAD), and other select psychiatric disorders such as obsessive-compulsive disorder (OCD). Citalopram A selective serotonin reuptake inhibitor (SSRI) used in the treatment of depression.
- Drugs & Drug Targets